Pfizer to start out pilot delivery programme because of its COVID-19 vaccine in 4 US states
17 November, 2020
Pfizer has launched a good pilot delivery programme because of its experimental COVID-19 vaccine in four American states, as america drugmaker seeks to handle distribution challenges facing it has the ultra-cold storage requirements.
Pfizer's vaccine, that was shown to become more than 90 percent effective found in preventing COVID-19 predicated on initial data, should be shipped and stored at -70 degrees Celsius, substantially below the typical for vaccines of 2 to 8 degrees Celsius.
"We are hopeful that results out of this vaccine delivery pilot will serve as the model for different US states and overseas governments, as they prepare to implement successful COVID-19 vaccine programmes," Pfizer explained in a statement on Monday (Nov 16).
It picked New Mexico, Rhode Island, Tennessee and Texas for the programme after considering their differences in total size, diversity of populations, immunisation infrastructure and have to reach individuals found in varied urban and rural adjustments.
The four states won't receive vaccine doses sooner than other states by virtue of the pilot, nor will they receive any differential consideration, Pfizer said.
The business expects to have sufficient safety info on the vaccine from the ongoing large-scale late-stage trials by the 3rd week of November before proceeding to use for emergency use authorisation (EUA).
Pfizer and its partner BioNTech have a US$1.95 billion package to provide 100 million doses of the vaccine to the US government, which has an option to obtain up to an additional 500 million doses.
Earlier on Monday, rival Moderna said its experimental vaccine was 94.5 percent effective in preventing COVID-19 predicated on interim info from a late-stage trial, improving hopes that vaccines against the condition could be ready for use soon.
Both Pfizer and Moderna vaccines use a fresh technology called synthetic messenger RNA to activate the disease fighting capability against the virus.
Source: www.channelnewsasia.com
TAG(s):